Aricept taken to task for alzheimer's claim

An advertisement for the anti Alzheimer's drug Aricept has been criticised for being misleading. The advertisement, which appeared in professional journals, suggested that the drug could help the condition.

London GP Dr Trisha Greenhalgh had complained that the advertisement made "a powerful claim for efficacy in a condition currently believed to be incurable and relentlessly progressive."

The Prescription Medicines Code of Practice Authority ruled that the advertisement did not give a balanced view of the scientific data. "There were insufficient data to support the impression given by the advertisement that memory in particular improved following treatment with Aricept," they ruled (BMJ 1998; 317: 766).

Related WDDTY Content

Hope for Alzheimers?

The pharmaceutical companies have spectacularly failed to move beyond the ‘chemical imbalance’ view of Alzheimer’s disease. But new evidence points to...

Alzheimer's disease - Metal fatigue

In the search for a magic bullet, orthodox medicine ignores preliminary evidence suggesting that some forms of dementia may be caused by metallic pois...

Hope for Alzheimer's?

The pharmaceutical companies have spectacularly failed to move beyond the ‘chemical imbalance’ view of Alzheimer’s disease. But new evidence points to...

Alzheimer's disease

Alzheimer's disease (AD) is one of the most misdiagnosed of modern diseases. True AD causes specific brain damage: microscopic senile plaques, brain...

The best alternative treatment for alzheimer’s disease - What to do instead

* Herbal medicine. Studies show that Ginkgo biloba can stop some of the major symptoms of cerebrovascular insufficiency. It is especially helpful in e...

A nutritional approach to Alzheimers

Re your article on Alzheimer's disease, I am so pleased that I have your backing